| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V28576 | 24-Norursodeoxycholic acid | 99697-24-2 | 24-Norursodeoxycholic acid (24-nor-Ursodeoxycholic acid; Norucholic acid; nor-UDCA), anan analog of ursodeoxycholic acid,isa side chain-shortened C23 homolog of UDCA with anti-inflammatory, anti-cholestatic, and anti-fibrotic activities. |
|
V6260 | 7-OH-DPAT Hydrobromide | 76135-30-3 | 7-OH-DPAT Hydrobromide is a novel, potent and selective Dopamine D3 receptor agonist with Ki values of 1, 10, 650 and ~ 5000 nM for D3, D2, D4 and D1 receptors respectively. |
|
V5790 | Bamaquimast | 135779-82-7 | Bamaquimast (F 10126; L 0042) is an effective antiasthmatic agent. |
|
V7204 | BI6015 | 93987-29-2 | BI-6015 is a hepatocyte nuclear factor 4α (HNF4α) antagonist that can inhibit the expression of known HNF4α target genes. |
|
V31626 | BPK-29 | 2143467-62-1 | BPK-29 is a novel, potent and selective ligand ofNR0B1that covalently binds to NR0B1 Cys 274 and inhibits the NR0B1-SNW1 interaction. |
|
V6898 | DCAI | 299165-92-7 | DCAI is a novel and potent inhibitor of nuleotide exchange and nucleotide release. |
|
V20095 | DL 071-IT hydrochloride | 55104-39-7 | DL 071IT is a potent, non-selective beta-adrenoceptor blocker. |
|
V20337 | E55888 | 1034142-33-0 | E55888 is a novel and potent agonist at the 5HT7 serotonin receptor |
|
V121025 | E55888 HCL | 1034142-33-0 | E55888 HCL is a novel and potent agonist at the 5HT7 serotonin receptor |
|
V28924 | INCB 3284 | 887401-92-5 | INCB3284 (INCB-3284) is a novel, potent and orally bioavailable CCR2 antagonist with the potential to be used foracute liver failure. |
|
V22869 | JC-D7 | 1036271-54-1 | JC-D7 (JCD7; JC D7) is a novel and selective fluorescent probe/dye used for specific labeling of synthetic polyphosphate (polyP) in vitro as well as endogenous polyP in living cells. |
|
V23003 | JTC-801 | 244218-93-7 | JTC-801 is a potent, orally bioactive and selective opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM, it weakly inhibits receptors δ, κ, and μ. |
|
V24869 | M-31850 | 281224-40-6 | M-31850 (M 31850; M31850) is a novel and potent β-Hexosaminidase inhibitor which exhibited activity against the insect β-N-acetyl-D-hexosaminidase of Hex2. |
|
V26423 | Nexinhib20 | 331949-35-0 | Nexinhib20 (neutrophil exocytosis inhibitor 20) is a novel and potentprotein-protein interaction inhibitor, inhibiting the interaction between the small GTPase Rab27a and its effector JFC1 (synaptotagmin-like protein1). |
|
V26502 | NIH-12848 | 959551-10-1 | NIH-12848 is a putative phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) inhibitor. |
|
V34655 | P-18 | P-18 (P18) is a novel and potent inhibitor of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 (PD-1/PD-L1) Interaction with IC50 of 9 nM in homogeneous time-resolved fluorescence (HTRF) binding assays. | |
|
V27058 | P7C3-A20 | 1235481-90-9 | P7C3-A20 (P 7C3-A20; P7C3A20) is a P7C3 derivative that acts as a proneurogenic and neuroprotective agent withneuroprotective activity. |
|
V5758 | P7C3-OMe | 1235481-43-2 | P7C3-OMe, formerly known as (R)-P7C3-OMe, is an analogue of P7C3 and P3C3-A20. |
|
V12597 | rel-Lifirafenib (rel-BGB-283) | 1446090-77-2 | rel-Lifirafenib (relative configuration) is a potent and selective RAF Kinase and EGFR inhibitor. |
|
V7140 | Rezatomidine (AGN203818) | 847829-38-3 | Rezatomidine is also know as AGN-203818. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
